Clinical trials
Coronary Artery Disease trials in Norway with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 6 |
| Norwegian University of Science and Technology | 5 |
| Haukeland University Hospital | 3 |
| Helse Stavanger HF | 2 |
| Vestre Viken Hospital Trust | 2 |
| Aarhus University Hospital Skejby | 1 |
| Abbott Medical Devices | 1 |
| CID - Carbostent & Implantable Devices | 1 |
| Herlev and Gentofte Hospital | 1 |
| Medical University of Vienna | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 29 |
| Angina Pectoris | 2 |
| Anxiety Disorders | 2 |
| Heart Failure | 2 |
| Inflammation | 2 |
| Myocardial Infarction | 2 |
| Angina, Stable | 1 |
| Angina, Unstable | 1 |
| Aortic Valve Disease | 1 |
| Aortic Valve Stenosis | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.